Literature DB >> 8057847

Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.

T Palzkill1, Q Q Le, K V Venkatachalam, M LaRocco, H Ocera.   

Abstract

In order to understand how TEM-1 beta-lactamase substrate specificity can be altered by mutation, amino acid residues 161 through to 170 were randomly mutagenized to sample all possible amino acid substitutions. The 161-170 region includes a portion of an omega loop structure, which is involved in the formation of the active-site pocket. The percentage of random sequences that provide bacterial resistance to either ampicillin or to the extended-spectrum cephalosporin ceftazidime was determined. It was found that the sequence requirements for wild-type levels of ampicillin resistance are much more stringent than the sequence requirements for ceftazidime resistance. Surprisingly, more than 50% of all amino acid substitutions in the 161-170 region result in levels of ceftazidime resistance at least three times greater than wild type. In addition, by increasing the level of the selection for ceftazidime resistance, substitutions that result in a greater than 100-fold increase in ceftazidime resistance were identified. Characterization of altered beta-lactamase enzymes indicated that while their catalytic efficiency (kcat/Km) for ceftazidime hydrolysis is higher, the enzymes are poorly expressed relative to wild-type TEM-1 beta-lactamase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057847     DOI: 10.1111/j.1365-2958.1994.tb01011.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  48 in total

1.  Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.

Authors:  Sergei Vakulenko; Dasantila Golemi
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  Sequences of the genes for the TEM-20, TEM-21, TEM-22, and TEM-29 extended-spectrum beta-lactamases.

Authors:  G Arlet; S Goussard; P Courvalin; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 3.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

4.  Protein evolution by codon-based random deletions.

Authors:  Joel Osuna; Jorge Yáñez; Xavier Soberón; Paul Gaytán
Journal:  Nucleic Acids Res       Date:  2004-09-30       Impact factor: 16.971

5.  Variability of chromosomally encoded beta-lactamases from Klebsiella oxytoca.

Authors:  B Fournier; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

6.  Experimental evolution of gene duplicates in a bacterial plasmid model.

Authors:  Alisha K Holloway; Timothy Palzkill; James J Bull
Journal:  J Mol Evol       Date:  2007-01-08       Impact factor: 2.395

7.  Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants.

Authors:  Krisztina M Papp-Wallace; Magdalena A Taracila; Julian A Gatta; Nozomi Ohuchi; Robert A Bonomo; Michiyoshi Nukaga
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

8.  Roles of amino acids 161 to 179 in the PSE-4 omega loop in substrate specificity and in resistance to ceftazidime.

Authors:  C Therrien; F Sanschagrin; T Palzkill; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

9.  Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site.

Authors:  Lori B Horton; Sreejesh Shanker; Rose Mikulski; Nicholas G Brown; Kevin J Phillips; Ernest Lykissa; B V Venkataram Prasad; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

10.  Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase.

Authors:  David C Marciano; Jeanine M Pennington; Xiaohu Wang; Jian Wang; Yu Chen; Veena L Thomas; Brian K Shoichet; Timothy Palzkill
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.